GlassScriptPhysician profile
Karen Smith Vanoy
NPI 1437256955
$4,635.50
in general payments reported to CMS, 2019-2025
17 companies · $1,070 in 2025
The $1,070 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,501 · 2020: $125 · 2021: $287 · 2022: $782 · 2023: $493 · 2024: $376 · 2025: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,940.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,133.17 | 2019-2025 | Precision 1, Tryptyr, Total30 |
| Coopervision INC. | $844.59 | 2021-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $371.69 | 2022-2025 | Miebo, Infuse, Xiidra |
| Johnson & Johnson Vision Care, INC. | $219.21 | 2019-2022 | |
| Sight Sciences, INC. | $198.28 | 2022-2024 | Tearcare System |
| Allergan, INC. | $161.82 | 2021-2022 | |
| New World Medical,INC. | $127.52 | 2025 | Ahmed Glaucoma Valve, Clearpath, Kahook Dual Blade |
| Sun Pharmaceutical Industries INC. | $121.60 | 2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $104.02 | 2019-2021 | |
| Glaukos Corporation | $102.30 | 2019 | |
| Harrow Eye, LLC | $80.52 | 2025 | Vevye |
| Novartis Pharmaceuticals Corporation | $49.24 | 2020-2023 | |
| Biotissue Holdings INC. | $34.99 | 2024 | |
| Dompe US, INC. | $29.66 | 2025 | Oxervate |
| Abbvie INC. | $25.74 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Vanoy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.